SEC Form 4 · accession 0001372514-26-000085
KIORA PHARMACEUTICALS INC · KPRX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Keith J. Lane
Other
Period of report
Sep 17, 2026
Accepted (ET)
Sep 17, 2026 · 9:35 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001372514
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $2.67 | Sep 17, 2026 | A | 55,000 | A | — | Sep 17, 2036 | Common Stock | 55,000 | 55,000 | D |
Explanation of responses
- F1The reporting person received an option to purchase Common Stock from the Issuer pursuant to the Plan. The option will become exercisable as to one-third (1/3) of the shares underlying the Option on September 17, 2027, and the remaining balance vests monthly on the last day of each calendar month thereafter for a period of two years, subject to the reporting person's continuous service through each such vesting date.